This occurs because Notch inhibition overcomes the resistance mechanisms activated in CLL cells by fludarabine [23], including increased NF-kB activation [48] and Mcl-1 expression [21]. The gene discussed is NFKB1; the disease is B-cell chronic lymphocytic leukemia.